Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,742,296
  • Shares Outstanding, K 111,436
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • EBIT $ -134 M
  • EBITDA $ -142 M
  • 60-Month Beta 1.00
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.30

Options Overview Details

View History
  • Implied Volatility 86.54% ( -1.32%)
  • Historical Volatility 91.32%
  • IV Percentile 28%
  • IV Rank 36.82%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.35
  • Today's Volume 601
  • Volume Avg (30-Day) 38,231
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 195,299
  • Open Int (30-Day) 218,457

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.28
  • Number of Estimates 10
  • High Estimate -0.24
  • Low Estimate -0.33
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -12.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.65 +6.40%
on 11/18/24
81.73 -37.97%
on 10/28/24
-13.64 (-21.20%)
since 10/21/24
3-Month
47.65 +6.40%
on 11/18/24
81.73 -37.97%
on 10/28/24
-14.06 (-21.71%)
since 08/21/24
52-Week
11.21 +352.19%
on 11/22/23
99.41 -49.00%
on 02/28/24
+39.35 (+346.70%)
since 11/21/23

Most Recent Stories

More News
3 Things You Need to Know if You Buy Viking Therapeutics Today

There aren't many biotechs that are more exciting than Viking Therapeutics (NASDAQ: VKTX) right now. Thanks to its clinical-stage candidate for weight loss, there's a real chance that this competitor could...

VKTX : 51.69 (+0.31%)
Is It Too Late to Buy Viking Therapeutics Stock?

Equity markets have performed well in 2024, but their showing pales next to that of Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech that rose in prominence this year. The drugmaker's shares are up...

VKTX : 51.69 (+0.31%)
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.

Mergers and acquisitions could make a comeback with Trump headed back to Washington.

VKTX : 51.69 (+0.31%)
NVO : 102.16 (-2.95%)
LLY : 744.59 (-1.17%)
Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has helped its earnings and its stock soar in recent times. It consists of the company's...

VKTX : 51.69 (+0.31%)
LLY : 744.59 (-1.17%)
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?

Viking Therapeutics just revealed a new plan that could make waves in the weight loss industry.

VKTX : 51.69 (+0.31%)
LLY : 744.59 (-1.17%)
Is Viking Therapeutics a Buy on the Dip?

Viking stock has slipped more than 20% from its peak.

VKTX : 51.69 (+0.31%)
NVO : 102.16 (-2.95%)
LLY : 744.59 (-1.17%)
4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move

All signs are pointing toward its continued success.

VKTX : 51.69 (+0.31%)
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag

The company's latest presentation supports the idea that its lead program will make billions.

VKTX : 51.69 (+0.31%)
LLY : 744.59 (-1.17%)
Is Viking Therepautics a Buy Now?

The clinical-stage drugmaker is developing an anti-obesity drug that could go on to produce record-breaking sales.

VKTX : 51.69 (+0.31%)
LLY : 744.59 (-1.17%)
Why Viking Therapeutics Stock Plummeted After Soaring Today

Are we ready for the Great Obesity Drug Gold Rush of the 2020s?

VKTX : 51.69 (+0.31%)
LLY : 744.59 (-1.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 55.55
2nd Resistance Point 54.30
1st Resistance Point 52.91
Last Price 51.69
1st Support Level 50.27
2nd Support Level 49.02
3rd Support Level 47.63

See More

52-Week High 99.41
Fibonacci 61.8% 65.72
Fibonacci 50% 55.31
Last Price 51.69
Fibonacci 38.2% 44.90
52-Week Low 11.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar